G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 28.05 SEK 3.13% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Genovis AB?
Write Note

Wall Street
Price Targets

GENO Price Targets Summary
Genovis AB

Wall Street analysts forecast GENO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GENO is 39.78 SEK with a low forecast of 30.3 SEK and a high forecast of 55.65 SEK.

Lowest
Price Target
30.3 SEK
8% Upside
Average
Price Target
39.78 SEK
42% Upside
Highest
Price Target
55.65 SEK
98% Upside
Genovis AB Competitors:
Price Targets
DIM
Sartorius Stedim Biotech SA
26% Upside
CHEMM
Chemometec A/S
18% Upside
WST
West Pharmaceutical Services Inc
15% Upside
688315
Novogene Co Ltd
50% Upside
TECN
Tecan Group AG
37% Upside
FLB
Fluidigm Corp
74% Upside
RVU
Ryvu Therapeutics SA
81% Upside
300463
Maccura Biotechnology Co Ltd
2% Upside

Revenue
Forecast

Revenue Estimate
Genovis AB

For the last 8 years the compound annual growth rate for Genovis AB's revenue is 36%. The projected CAGR for the next 3 years is 6%.

36%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genovis AB

The compound annual growth rate of Genovis AB's operating income for the next 3 years is 3%.

N/A
Past Growth
3%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Genovis AB

The compound annual growth rate of Genovis AB's net income for the next 3 years is -9%.

N/A
Past Growth
-9%
Estimated Growth
Estimates Accuracy
-37%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENO's stock price target?
Price Target
39.78 SEK

According to Wall Street analysts, the average 1-year price target for GENO is 39.78 SEK with a low forecast of 30.3 SEK and a high forecast of 55.65 SEK.

What is Genovis AB's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Genovis AB's revenue is 36%. The projected CAGR for the next 3 years is 6%.

What is Genovis AB's Operating Income forecast?
Projected CAGR
3%

The compound annual growth rate of Genovis AB's operating income for the next 3 years is 3%.

What is Genovis AB's Net Income forecast?
Projected CAGR
-9%

The compound annual growth rate of Genovis AB's net income for the next 3 years is -9%.

Back to Top